Is INBX or IPHA more undervalued in 2026?

CirclFi compares Inhibrx Biosciences, Inc. (INBX) and Innate Pharma S.A. (IPHA) using 13 institutional-grade valuation models. INBX has a Quality of Company score of 5.3/10 while IPHA scores 4.8/10.

Which is a better buy — INBX or IPHA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INBX and IPHA valuations compare?

INBX at $104.01 and IPHA at $1.83 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INBX vs IPHA Valuation Comparison 2026 — Intrinsic Value Analysis

INBX

Biological Products, (No Diagnostic Substances)

Inhibrx Biosciences, Inc.

Quality

5.3

out of 10

Value Trap

SAFE

Price

$104.01

Last close

Models

8/13

Active

IPHA

Biological Products, (No Diagnostic Substances)

Innate Pharma S.A.

Quality

4.8

out of 10

Value Trap

LOW

Price

$1.83

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	INBX Fair Value	INBX Upside	IPHA Fair Value	IPHA Upside
Bayesian DCF	Intrinsic	$29.90	-71.3%	$0.62	-66.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.89	-97.2%	$0.87	-52.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INBX vs IPHA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INBX vs IPHA — Which Stock Is More Undervalued?

INBX scores higher with a 5.3/10 quality rating vs IPHA's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inhibrx Biosciences, Inc. (INBX) and Innate Pharma S.A. (IPHA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INBX currently trades at $104.01 with a QOC of 5.3/10, while IPHA trades at $1.83 with a QOC of 4.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).